These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 134673)

  • 1. Letter: Dermatosis induced by practolol.
    Kauppinen K; Niemi KM; Salo OP
    Arch Dermatol; 1976 Oct; 112(10):1472. PubMed ID: 134673
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Skin rash, conjunctivitis and plastic peritonitis with practolol therapy.
    Scott DF; Williams P
    Med J Aust; 1975 Jan; 1(2):44-5. PubMed ID: 124008
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Report on adverse reactions associated with practolol.
    Proctor CR
    Med J Aust; 1974 Nov; 2(20):758. PubMed ID: 4280498
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Skin reactions to practolol.
    Felix R; Ive FA
    Br Med J; 1974 May; 2(5914):333. PubMed ID: 4275063
    [No Abstract]   [Full Text] [Related]  

  • 5. [A patient with skin eruptions due to practolol].
    Faber WR; Hulsebosch HJ; Overdijk AD; van der Upwich WG
    Ned Tijdschr Geneeskd; 1976 Jan; 120(4):165-7. PubMed ID: 128703
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Skin reactions to practolol.
    Wright P
    Br Med J; 1974 Jun; 2(5918):560. PubMed ID: 4276108
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complications in treatment with beta blockader Practolol (Eraldin)].
    Brinck HP; Aasved H; Jacobsen KB
    Tidsskr Nor Laegeforen; 1975 Aug; 95(24):1357-9, 1352. PubMed ID: 126503
    [No Abstract]   [Full Text] [Related]  

  • 8. [Practolol (Eraldin)].
    van der Meer J
    Ned Tijdschr Geneeskd; 1975 Jun; 119(25):999-1000. PubMed ID: 49864
    [No Abstract]   [Full Text] [Related]  

  • 9. [Actual late effects. Skin, eye and hearing changes during treatment with practolol (Eraldin)].
    Ugeskr Laeger; 1975 Apr; 137(18):1016-7. PubMed ID: 124969
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome.
    Amos HE; Lake BG; Artis J
    Br Med J; 1978 Feb; 1(6110):402-4. PubMed ID: 146533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conjunctivitis, stomatitis, glossitis, otitis and psoriasiform skin diseases during long-term treatment with practolol (Eraldin)].
    Byrn E; Reersted P
    Ugeskr Laeger; 1975 Apr; 137(18):1019-20. PubMed ID: 124970
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug eruptions caused by beta-blockers].
    Bonnetblanc JM
    Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of practolol.
    Nicholls JT
    Ann Clin Res; 1976 Aug; 8(4):229-31. PubMed ID: 136918
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adverse effects of practolol].
    Ahonen A
    Duodecim; 1976; 92(22):1264-5. PubMed ID: 137109
    [No Abstract]   [Full Text] [Related]  

  • 15. The elimination of practolol by two human subjects.
    Dring LG; Gorchein A; Mahgoub AA; Smith RL
    Br J Clin Pharmacol; 1978 Mar; 5(3):262-5. PubMed ID: 148896
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous and ocular reactions to practolol.
    Felix RH; Ive FA; Dahl MG
    Br Med J; 1974 Nov; 4(5940):321-4. PubMed ID: 4279720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practolol and deafness.
    Jones RF; Hammond VT; Wright D; Ballantyne JC
    J Laryngol Otol; 1977 Nov; 91(11):963-72. PubMed ID: 145453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is this psoriasis vulgaris?].
    van Joost T
    Ned Tijdschr Geneeskd; 1979 Dec; 123(51):2169-72. PubMed ID: 161800
    [No Abstract]   [Full Text] [Related]  

  • 19. Practolol-induced autoantibodies and their relation to oculo-cutaneous complications.
    Jachuck SJ; Stephenson J; Bird T; Jackson FS; Clark F
    Postgrad Med J; 1977 Feb; 53(616):75-7. PubMed ID: 141660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Review: beta-blocking agents in dermatology (author's transl)].
    Clerens A; Guilmot-Bruneau MM; Defresne C; Bourlond A
    Dermatologica; 1981; 163(1):5-11. PubMed ID: 6115777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.